NOVABAY PHARMACEUTICALS INC (NBY) Stock News
NYSEARCA:NBY - NYSE Arca - US66987P4090 - Common Stock - Currency: USD
NBY Latest News, Press Relases and Analysis
Brookdale Senior Living (BKD) Reports Q1 Loss, Lags Revenue Estimates
Brookdale (BKD) delivered earnings and revenue surprises of 0% and 0.81%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: BKD
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
Why NovaBay Pharmaceuticals (NBY) Stock Is Down 60%
NovaBay Pharmaceuticals shares are trading lower by 61% during Friday's session. The company announced the pricing of its public offering.
NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
NBY stock results show that NovaBay Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!
NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
Mentions: EYEN
NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning!